VIR BIOTECHNOLOGY INC VIR

US Healthcare Biological Products, (No Diagnostic Substances)
$10.04
+5.0%
52w: $4.28 – $11.09

Latest 13F among current holders filed 19 days ago (Jun 16, 2026)

Price — last 12 months

research preview data
4.287.6911.09
Jun 20, 2025 Jul 2, 2026
Institutional holders
252
+34 QoQ
13F value
$1.26B
+79.7% QoQ
Smart-money holders
19
signal tier ≥ 2
New smart buyers
9
Q1 2026
Options barometer
1.4×
$4.5M calls / $3.4M puts

Institutional value by quarter

$967.7M
Q1 2024
$794.3M
Q2 2024
$664.4M
Q3 2024
$652.1M
Q4 2024
$604.6M
Q1 2025
$562.0M
Q2 2025
$613.6M
Q3 2025
$698.5M
Q4 2025
$1.26B
Q1 2026

Number of holders

212
Q1 2024
216
Q2 2024
198
Q3 2024
209
Q4 2024
235
Q1 2025
214
Q2 2025
213
Q3 2025
218
Q4 2025
252
Q1 2026

Who owns VIR?

Q1 2026 filings
FundTypeSharesValue% of fundChange
BlackRock, Inc. Index provider18.0M$161.3M0.0%+10.2%
ARCH Venture Management, LLC ★3Fundamental concentrated12.9M$115.7M17.1%Held
SB INVESTMENT ADVISERS (UK) LTD ★3Fundamental concentrated10.9M$98.1M1.3%-16.5%
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical9.2M$82.6M0.0%
GSK plc ★3Fundamental concentrated8.6M$76.6M12.8%Held
STATE STREET CORP Index provider7.1M$64.0M0.0%+14.6%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical5.4M$48.2M0.0%
GOLDMAN SACHS GROUP INC Bank broker3.3M$29.1M0.0%+107.2%
MORGAN STANLEY Bank broker2.9M$25.6M0.0%+6.5%
ADAR1 Capital Management, LLC Other2.7M$24.6M1.5%New
GEODE CAPITAL MANAGEMENT, LLC Index provider2.7M$23.8M0.0%+14.2%
DIMENSIONAL FUND ADVISORS LP Quant stat arb2.6M$23.1M0.0%+1.7%
CITADEL ADVISORS LLC Multistrat pod2.1M$18.8M0.0%+328.9%
FMR LLC Long only active2.1M$18.6M0.0%-34.4%
Soleus Capital Management, L.P. ★2Fundamental diversified2.0M$17.9M0.7%New
Point72 Asset Management, L.P. Multistrat pod2.0M$17.5M0.0%+897.5%
Boxer Capital Management, LLC ★2Fundamental concentrated1.9M$16.7M2.2%+198.6%
Avidity Partners Management LP ★2Fundamental diversified1.6M$14.8M1.6%New
GordonMD Global Investments LP ★3Fundamental concentrated1.5M$13.6M9.5%+63.2%
Sio Capital Management, LLC ★2Fundamental concentrated1.5M$13.4M1.9%+213.3%
Pictet Asset Management Holding SA Diversified mechanical1.5M$13.3M0.0%+10878.9%
Hudson Bay Capital Management LP Multistrat pod1.5M$13.2M0.1%+10.9%
JACOBS LEVY EQUITY MANAGEMENT, INC Other1.4M$12.9M0.1%New
TWO SIGMA INVESTMENTS, LP Quant stat arb1.4M$12.9M0.0%+144.2%
Qube Research & Technologies Ltd Quant stat arb1.2M$11.2M0.0%+1403.4%
Clearstead Advisors, LLC Wealth advisor1.2M$10.9M0.1%New
Jones Hill Capital LP ★3Fundamental concentrated1.2M$10.7M2.3%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider1.2M$10.5M0.0%+29.5%
Candriam S.C.A. Other1.1M$10.2M0.1%+10.1%
BNP PARIBAS FINANCIAL MARKETS Bank broker1.1M$9.7M0.0%+285.5%
Ensign Peak Advisors, Inc Diversified mechanical1.1M$9.6M0.0%+101.5%
JPMORGAN CHASE & CO Bank broker1.1M$9.5M0.0%+167.0%
Nuveen, LLC Diversified mechanical1.0M$9.1M0.0%+80.2%
NORTHERN TRUST CORP Index provider985.4K$8.8M0.0%+16.1%
BANK OF AMERICA CORP /DE/ Bank broker965.8K$8.7M0.0%+3.7%
D. E. Shaw & Co., Inc. Quant stat arb817.7K$7.3M0.0%+1542.2%
RENAISSANCE TECHNOLOGIES LLC Quant stat arb761.4K$6.8M0.0%+23.9%
UBS Group AG Bank broker744.1K$6.7M0.0%+78.0%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical731.7K$6.6M0.0%
SUPERSTRING CAPITAL MANAGEMENT LP ★2Fundamental concentrated730.5K$6.5M4.7%New
Walleye Capital LLC Multistrat pod665.6K$6.0M0.0%+159.9%
Bank of New York Mellon Corp Diversified mechanical584.0K$5.2M0.0%+7.1%
NORDEA INVESTMENT MANAGEMENT AB Other580.8K$5.1M0.0%-4.8%
AQR CAPITAL MANAGEMENT LLC Quant stat arb566.0K$5.1M0.0%+203.8%
PRINCIPAL FINANCIAL GROUP INC Diversified mechanical547.8K$4.9M0.0%+21.6%
Empyrean Capital Partners, LP ★2Fundamental diversified527.8K$4.7M0.2%New
Alta Partners Management Company, L.P. ★2Fundamental diversified509.9K$4.6M3.0%Held
Parkman Healthcare Partners LLC Other500.0K$4.5M0.5%New
MILLENNIUM MANAGEMENT LLC Multistrat pod489.4K$4.4M0.0%-51.2%
ALGERT GLOBAL LLC Diversified mechanical489.0K$4.4M0.1%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.